DYSPLASTIC NEVI AS A MELANOMA RISK FACTOR IN PATIENTS WITH FAMILIAL MELANOMA

被引:0
|
作者
CAREY, WP
THOMPSON, CJ
SYNNESTVEDT, M
GUERRY, D
HALPERN, A
SCHULTZ, D
ELDER, DE
机构
[1] UNIV PENN,SCH MED,DEPT MED,PHILADELPHIA,PA
[2] UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,PHILADELPHIA,PA
[3] UNIV PENN,SCH MED,DEPT DERMATOL,PHILADELPHIA,PA
[4] UNIV PENN,SCH MED,PIGMENTED LESION STUDY GRP,PHILADELPHIA,PA
关键词
MELANOMA; FAMILIAL MELANOMA; HEREDITARY; DYSPLASTIC NEVI; ATYPICAL NEVI; NEVI; RISK;
D O I
10.1002/1097-0142(19941215)74:12<3118::AID-CNCR2820741210>3.0.CO;2-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Familial melanoma has been associated with ''clinically atypical moles'' or ''dysplastic nevi,'' (DN) which are markers for increased melanoma risk. In addition, melanomas in these kindreds present at a younger age, and tend to be multiple. Methods. Melanoma incidence rates were determined for 710 members of 311 melanoma families, defined as kindreds in which melanoma had occurred in two or more blood relatives. Patients were classified either clinically or histologically as expressing DN. Melanomas that occurred before the first examination were recorded, and patients were followed prospectively for new melanomas. Results. In prospective follow-up, the age-adjusted melanoma incidence rate was 1710/100,000 patient-years in family members with DN. In contrast, the rate was zero (no melanomas occurred) in family members without DN. For family members with DN, but without a history of melanoma, the age-adjusted incidence rate of melanoma was 413/100,000 patient-years, whereas the rate was 2779/100,000 patient-years in family members with DN and a history of melanoma. Conclusions. Dysplastic nevi and a history of melanoma are strong risk factors for subsequent melanoma. Prognostic factors are greatly improved for patients with melanomas diagnosed in follow-up compared with the first two melanomas in each kindred. These findings warrant surveillance of individuals with DN who are members of familial melanoma kindreds.
引用
收藏
页码:3118 / 3125
页数:8
相关论文
共 50 条
  • [1] CUTANEOUS DYSPLASTIC NEVI - RISK FACTOR FOR UVEAL MELANOMA
    HAMMER, H
    TOTHMOLNAR, E
    OLAH, J
    DOBOZY, A
    [J]. LANCET, 1995, 346 (8969): : 255 - 256
  • [2] Risk of cutaneous malignant melanoma in patients with non-familial dysplastic nevi.
    Snels, DGCTM
    Bergman, W
    Gruis, NA
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (03) : 72 - 72
  • [3] Dysplastic Nevi and Melanoma
    Goldstein, Alisa M.
    Tucker, Margaret A.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (04) : 528 - 532
  • [4] Dysplastic nevi and other risk markers for melanoma
    Seykora, J
    Elder, D
    [J]. SEMINARS IN ONCOLOGY, 1996, 23 (06) : 682 - 687
  • [5] Clinically recognized dysplastic nevi - A central risk factor for cutaneous melanoma
    Tucker, MA
    Halpern, A
    Holly, EA
    Hartge, P
    Elder, DE
    Sagebiel, RW
    Guerry, D
    Clark, WH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (18): : 1439 - 1444
  • [6] DYSPLASTIC NEVI - MARKERS FOR INCREASED RISK FOR MELANOMA
    RIGEL, DS
    RIVERS, JK
    KOPF, AW
    FRIEDMAN, RJ
    VINOKUR, AF
    HEILMAN, ER
    LEVENSTEIN, M
    [J]. CANCER, 1989, 63 (02) : 386 - 389
  • [7] DEPENDENCE OF TOTAL NEVI ON DYSPLASTIC NEVI IN DETERMINING RISK FOR MELANOMA
    ROUSH, GC
    MCKAY, L
    NORDLUND, J
    FORGET, B
    TITUS, L
    KIRKWOOD, J
    [J]. PREVENTIVE MEDICINE, 1986, 15 (06) : 699 - 700
  • [8] DYSPLASTIC NEVI IN PATIENTS WITH CUTANEOUS AND INTRAOCULAR MELANOMA
    TAYLOR, MR
    GUERRY, D
    BONDI, EE
    SHIELDS, JA
    AUGSBURGER, JJ
    LUSK, EJ
    ELDER, DE
    CLARK, WH
    VANHORN, M
    [J]. CLINICAL RESEARCH, 1983, 31 (02): : A413 - A413
  • [9] A COHORT STUDY OF MELANOMA IN PATIENTS WITH DYSPLASTIC NEVI
    HALPERN, AC
    GUERRY, D
    ELDER, DE
    TROCK, B
    SYNNESTVEDT, M
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (03) : S346 - S349
  • [10] DYSPLASTIC NEVI, MELANOMA AND SUNLIGHT
    KRAEMER, KH
    [J]. PHOTODERMATOLOGY, 1987, 4 (05) : 227 - 229